Are We Measuring Metabolic Health All Wrong?
A fragmented system built on isolated metrics like BMI and A1C fails to capture the full picture of metabolic health and limits our ability to manage it effectively.
The Promise and Challenge of GLP-1 Medications: Ensuring ROI in Obesity Care
Pricy GLP-1 medications are here to stay — let's focus on turning their potential into lasting, meaningful impact.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
Why Medicare Should Treat Obesity as a Disease
Medicare is failing its beneficiaries by not treating obesity as a disease. Just like people with high blood pressure often need to take medications to avoid disease-related complications, people with obesity need access to all appropriate, evidence-based therapies to combat the disease.